A novel in vitro model of primary human pediatric lung epithelial cells

Qian Wang1,2,3, Soumyaroop Bhattacharya1,2, Jared A Mereness1,2,4

  • 1Division of Neonatology, University of Rochester Medical Center, Rochester, NY, USA.

Pediatric Research
|February 19, 2019
PubMed

Insights

Researchers developed a new method to grow and differentiate pediatric human lung epithelial (PHLE) cells. These cells accurately model the pediatric airway, aiding research into lung development and disease.

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Developmental Biology

Background:

  • Current in vitro models using adult lung cells may not fully represent pediatric lung physiology.
  • Understanding pediatric lung development and disease requires accurate cellular models.

Purpose of the Study:

  • To establish and characterize primary Pediatric Human Lung Epithelial (PHLE) cells from infant lung tissue.
  • To provide a novel in vitro model for studying pediatric lung mechanisms.

Main Methods:

  • Primary PHLE cells were isolated from infant lung organ donors.
  • Cells were cultured, expanded, and differentiated at air-liquid interface (ALI).
  • Characterization involved immunohistochemistry, flow cytometry, RT-PCR, and single-cell RNA sequencing (scRNAseq).

Main Results:

  • PHLE cells were successfully expanded and retained epithelial characteristics.
  • Differentiated PHLE cells at ALI expressed airway epithelial lineage markers.
  • scRNAseq identified four main sub-phenotypes (FOXJ1, KRT5, MUC5B, SFTPB).

Conclusions:

  • PHLE cells offer a unique human in vitro model of the pediatric airway epithelium.
  • This model is suitable for investigating perinatal development and pediatric lung diseases.
  • These cells are accessible to the research community via the Developing Lung Molecular Atlas Program.
Abstract

Related Concept Videos

Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
213
Primary Active Transport01:47

Primary Active Transport

In contrast to passive transport, active transport involves a substance being moved through membranes in a direction against its concentration or electrochemical gradient. There are two types of active transport: primary active transport and secondary active transport. Primary active transport utilizes chemical energy from ATP to drive protein pumps that are embedded in the cell membrane. With energy from ATP, the pumps transport ions against their electrochemical gradients—a direction...
198.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
272